OHLCX Market Research
Delayed

EW

Edwards Lifesciences specializes in heart valve therapies and critical care monitoring.

−2.03 (−1.95%) Nov 20, 2026 16:01 ET Delayed
Open
103.84
High
104.96
Low
101.65
Prev close
103.88
Volume
3M
Avg vol 10
4M

Today · Market closed · opens Mon 9:30 AM

Price

EW chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 101.85

Strong sellNeutralStrong buy
Buy
score +0.17 · 18 signalling
6Buy
9Neutral
3Sell

Leaning buy. 6 of 18 signals point up against 3 down, carried by momentum. Trend is mostly neutral. Volatility is mostly neutral. Volume is mostly neutral. Trend strength is strong (ADX 36).

How to read this →

Trend

MACD 12, 26, 9
Below signal line, still above zero
MACD 3.99 · Signal 4.18 · Hist −0.19
Sell
ADX 14
Strong trend, +DI ahead
ADX 36.10 · +DI 25.21 · −DI 17.00
Buy
Parabolic SAR 0.02, 0.2
Above price, 6.15 over the close
108.00
Sell
Ichimoku 9, 26, 52
Price above cloud, conversion above base
Conv 104.83 · Base 97.05 · A 85.74 · B 88.17
Buy

Momentum

RSI 14
Mid-range, no extreme
59.21
Neutral
Stoch 14, 3
Mid-range, %K still below %D
%K 58.25 · %D 74.66
Neutral
Stoch RSI 14, 14, 3, 3
Low, %K still below %D
%K 27.12 · %D 49.90
Neutral
Williams %R 14
Mid-range, falling
−41.75
Neutral
CCI 14
Negative, above −100
−12.34
Neutral
MFI 14
Above midpoint, not overbought
58.94
Neutral
ROC 12
Price up 2.50% over 12 bars
+2.50%
Buy
AO 5, 35
Above zero, falling
10.90
Neutral
TRIX 18
Above zero
0.547
Buy
KST 10/15/20/30, 3
Above its signal line
KST 179.84 · Signal 179.77
Buy

Volatility

Bollinger 20, 2
Upper half, %b 0.58
Up 111.84 · Mid 100.07 · Low 88.30
Neutral
Keltner 20, 10, 1.5
Inside the channel, upper half
Up 104.90 · Mid 100.50 · Low 96.11
Neutral

Volume

VWAP 345-bar
Close 21.1% above VWAP
84.07
Buy
Force Index 1
Negative, sellers in control
−7.4M
Sell
ATR
2.87
2.81% of close
A/D Line
52.2M
cumulative
OBV
101.8M
cumulative
Volume Profile
82.50 – 85.05
POC · bull 256.0M · bear 299.7M · 46 / 54
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

13.05%

Change in value over the past month.

3 month return

12.54%

Change in value over the last three months.

Max drawdown

13.19%

Largest fall from a peak to the low that followed.

Standard deviation

26.23%

How far daily returns stray from their average, annualised.

Sharpe ratio

0.89

Return above the risk-free rate per unit of volatility.

Calmar ratio

1.77

Annualised return against the maximum drawdown.

About

EW summary

Loading summary…

Questions

EW, answered

Is Edwards Lifesciences publicly traded?

Yes, Edwards Lifesciences is publicly traded on the New York Stock Exchange under the ticker symbol EW.

How can I access Edwards Lifesciences’ financial reports?

You can find financial reports on their investor relations website, including annual and quarterly reports.

What factors influence the stock price of Edwards Lifesciences?

Factors include product approvals, market demand, competition, and overall healthcare market trends.

How does Edwards Lifesciences support innovation?

Edwards invests significantly in research and development to innovate and improve its medical devices.

What is the future outlook for Edwards Lifesciences?

The outlook depends on continued innovation, market expansion, and regulatory approvals for new products.

Where can I find news about Edwards Lifesciences?

News can be found on financial news websites and the company’s official press releases.

What is Edwards Lifesciences’ current market capitalization?

Market capitalization fluctuates; check financial platforms for the latest data on EW.

Does Edwards Lifesciences pay dividends?

As of now, Edwards Lifesciences does not pay a regular dividend.

How does Edwards Lifesciences ensure product safety?

Edwards follows rigorous testing and regulatory processes to ensure the safety and efficacy of its products.

What do analysts say about Edwards Lifesciences stock?

Analyst opinions and ratings are available on investment research platforms and financial news sites.

News

EW in the news

Enhance Your EW Trading Now

Unlock the full potential of EW with OHLCX.com’s cutting-edge automated trading system. Our platform provides precise price action analysis, advanced technical indicators, and powerful quantitative algorithms. Start optimizing your trades today and transform your trading experience today!

Unlock Full Potential Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.